HIVE Stock Chart & Stats
$1.25
$0.00(0.00%)
At close: 4:00 PM EST
$1.25
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.00 - $0.00
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
₪4.02M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,209,900
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HIVE FAQ
What was HIVE 2040 R&D LIMITED PARTNERSHIP’s price range in the past 12 months?
HIVE 2040 R&D LIMITED PARTNERSHIP lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
What is HIVE 2040 R&D LIMITED PARTNERSHIP’s market cap?
HIVE 2040 R&D LIMITED PARTNERSHIP’s market cap is ₪4.02M.
When is HIVE 2040 R&D LIMITED PARTNERSHIP’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HIVE 2040 R&D LIMITED PARTNERSHIP’s earnings last quarter?
Currently, no data Available
Is HIVE 2040 R&D LIMITED PARTNERSHIP overvalued?
According to Wall Street analysts HIVE 2040 R&D LIMITED PARTNERSHIP’s price is currently Overvalued.
Does HIVE 2040 R&D LIMITED PARTNERSHIP pay dividends?
HIVE 2040 R&D LIMITED PARTNERSHIP does not currently pay dividends.
What is HIVE 2040 R&D LIMITED PARTNERSHIP’s EPS estimate?
HIVE 2040 R&D LIMITED PARTNERSHIP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HIVE 2040 R&D LIMITED PARTNERSHIP have?
HIVE 2040 R&D LIMITED PARTNERSHIP has 3,209,900 shares outstanding.
What happened to HIVE 2040 R&D LIMITED PARTNERSHIP’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HIVE 2040 R&D LIMITED PARTNERSHIP?
Currently, no hedge funds are holding shares in IL:HIVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HIVE 2040 R&D LIMITED PARTNERSHIP
This Israel-based entity functions as a venture capital fund, primarily focused on supporting research and development initiatives.